|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
NCI - Center for Cancer Research-Medical Oncology National Cancer Institute (NCI) |
| Information provided by: | National Cancer Institute (NCI) |
| ClinicalTrials.gov Identifier: | NCT00019149 |
Purpose
RATIONALE: Evaluating patients who have skin diseases may help doctors plan more effective treatment and follow-up for skin diseases and systemic diseases that show up in the skin.
PURPOSE: This clinical trial is studying and following patients with skin diseases.
| Condition | Intervention |
|
Lymphoma Melanoma (Skin) |
Procedure: biopsy Procedure: electron microscopy Procedure: flow cytometry Procedure: fluorescent antibody technique Procedure: immunoenzyme technique Procedure: immunohistochemistry staining method Procedure: microscopy Procedure: polymerase chain reaction Procedure: radiography |
| MedlinePlus related topics: | Fungal Infections Lymphoma Melanoma Skin Conditions |
| Drug Information available for: | X-Rays |
| Study Type: | Interventional |
| Study Design: | Diagnostic, Open Label |
| Official Title: | Evaluation and Treatment of Subjects With Dermatologic Diseases |
| Estimated Enrollment: | 500 |
| Study Start Date: | June 1996 |
| Estimated Primary Completion Date: | December 2016 (Final data collection date for primary outcome measure) |
OBJECTIVES:
OUTLINE: Samples of blood, urine, stool, exudates, skin scrapings, hair, and nails are collected from patients and then are analyzed, as medically indicated, using the following diagnostic tests:
Immunopathologic tests, including:
PROJECTED ACCRUAL: A total of 500 patients will be accrued for this study.
Eligibility
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
Age:
Performance status:
Life expectancy:
Hematopoietic:
Hepatic:
Renal:
Other:
PRIOR CONCURRENT THERAPY:
Biologic therapy
Chemotherapy
Endocrine therapy
Radiotherapy
Surgery
Contacts and Locations| United States, Maryland | |||||
| Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office | Recruiting | ||||
| Bethesda, Maryland, United States, 20892-1182 | |||||
| Contact: Patient Recruitment 888-NCI-1937 | |||||
| NCI - Center for Cancer Research-Medical Oncology |
| National Cancer Institute (NCI) |
| Study Chair: | Mark C. Udey, MD, PhD | NCI - Dermatology Branch |
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database 
  |
| Study ID Numbers: | CDR0000064802, NCI-96-C-0102 |
| First Received: | July 11, 2001 |
| Last Updated: | October 18, 2008 |
| ClinicalTrials.gov Identifier: | NCT00019149 |
| Health Authority: | Unspecified |
|
|
|
|
|